Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma.

Mooney B, Chu X, Negri GL, Lizardo MM, Song H, Marsh A, Delaidelli A, Huang YZ, Rouleau M, Spencer SE, Shraim R, Hamilton AK, Magesh S, Zhang W, Budhathoki Y, Cannon MV, Roberts R, Gorlick R, Sweet-Cordero A, Diskin SJ, Maris JM, Li W, Morin GB, Sorensen PH